Plerixafor

Generic: Plerixafor

Labeler: Teva Pharmaceuticals, Inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name Plerixafor
Generic Name Plerixafor
Labeler Teva Pharmaceuticals, Inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

PLERIXAFOR 24 mg/1.2mL

Identifiers & Regulatory

Product NDC 0480-4320
Product ID 0480-4320_389f8557-7dbc-40ac-8b68-e8e1a83f6325
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205197
Marketing Start 2023-07-28
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04804320
Hyphenated Format 0480-4320

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Plerixafor (source: ndc)
Generic Name Plerixafor (source: ndc)
Application Number ANDA205197 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 24 mg/1.2mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4320-01) / 1.2 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

PLERIXAFOR (24 mg/1.2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "389f8557-7dbc-40ac-8b68-e8e1a83f6325", "openfda": {"nui": ["N0000178326", "N0000178324"], "upc": ["0304804320013"], "unii": ["S915P5499N"], "rxcui": ["828700"], "spl_set_id": ["7027572d-cce6-42a7-9481-ec37c65fd460"], "pharm_class_pe": ["Increased Hematopoietic Stem Cell Mobilization [PE]"], "pharm_class_epc": ["Hematopoietic Stem Cell Mobilizer [EPC]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4320-01)  / 1.2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0480-4320-01", "marketing_end_date": "20260228", "marketing_start_date": "20230728"}], "brand_name": "Plerixafor", "product_id": "0480-4320_389f8557-7dbc-40ac-8b68-e8e1a83f6325", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Hematopoietic Stem Cell Mobilizer [EPC]", "Increased Hematopoietic Stem Cell Mobilization [PE]"], "product_ndc": "0480-4320", "generic_name": "Plerixafor", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Plerixafor", "active_ingredients": [{"name": "PLERIXAFOR", "strength": "24 mg/1.2mL"}], "application_number": "ANDA205197", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20230728"}